Apcotex Industries Ltd (APCOTEXIND) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- Management will fund the entire INR 210 crore NBR and SBR capex through internal accruals, reflecting strong cash generation.
- The board is delaying the decision on further Nitrile Latex expansion, seeking more quarters of stable margins before committing capital.
- Management is prioritizing volume growth and ROCE, accepting a 12% EBITDA margin in a high-cost environment over a targeted 15%.
Performance Overview
- Delivered a strong 48% year-on-year revenue growth in Q2 FY27, driven by a 7% increase in sales volumes.
- Successfully reversed the decline in export volumes seen in Q1, despite ongoing geopolitical and freight challenges.
- Maintained a net cash positive position, demonstrating financial resilience despite elevated working capital due to higher input costs.
- Progress on the INR 210 crore Capex projects at the Valia facility remains on track, supporting future growth.
- Management focused on protecting volumes and maintaining ROCE, even if it meant accepting slightly lower percentage-based EBITDA margins.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.